CompletedNCT03263195
Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
Studying Zika virus disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Westat
- Principal Investigator
- Marisa M. Mussi-Pinhata, MDUniversity of Sao Paolo, Riberao Preto Medical School, Department of Pediatrics
- Enrollment
- 395 target
- Eligibility
- 15 years · FEMALE
- Timeline
- 2017 – 2020
Study locations (11)
- University of Miami Pediatric/Prenatal HIV/AIDS, Miami, Florida, United States
- Bronx-Lebanon Hospital Center NICHD CRS, The Bronx, New York, United States
- Baylor College of Medicine; Texas Children's Hospital, Houston, Texas, United States
- Baylor College of Medicine, Houston, Texas, United States
- SOM Federal University Minas Gerais Brazil NICHD CRS, Belo Horizonte, Minas Gerais, Brazil
- Hospital Federal dos Servidores do Estado NICHD CRS, Rio de Janeiro, Brazil
- Instituto de Puericultura e Pediatria Martagao Gesteira - UFRJ NICHD CRS, Rio de Janeiro, Brazil
- Hosp. Geral De Nova Igaucu Brazil NICHD CRS, Rio de Janeiro, Brazil
- University of Sao Paulo at Riberaio Preto Brazil, São Paulo, Brazil
- University of Puerto Rico Pediatrics HIV/AIDS Research Program, San Juan, Puerto Rico
- San Juan City Hosp. PR NICHD CRS, San Juan, Puerto Rico
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03263195 on ClinicalTrials.govOther trials for Zika virus disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT04398901Neurodevelopmental Outcomes in ZIKV-Exposed ChildrenChildren's National Research Institute
- ACTIVE NOT RECRUITINGPHASE3NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCerus Corporation
- RECRUITINGNCT01386424Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNational Institute of Allergy and Infectious Diseases (NIAID)